Clinical Trial Update: Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intermittent inhaled nitric oxide for bronchiolitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Drugs mentioned

• Nitric oxide inhalation (nitric oxide)

Snippet

Sponsor: Beyond Air Inc. | Conditions: Bronchiolitis | Phase 3 | Status: COMPLETED